3L3 Stock Overview
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Tactile Systems Technology, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$13.40 |
| 52 Week High | US$23.40 |
| 52 Week Low | US$9.15 |
| Beta | 1.21 |
| 1 Month Change | -9.46% |
| 3 Month Change | -3.60% |
| 1 Year Change | -14.65% |
| 3 Year Change | -72.43% |
| 5 Year Change | -69.20% |
| Change since IPO | -46.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3L3 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.5% | -0.6% | 1.8% |
| 1Y | -14.6% | -9.5% | 2.2% |
Return vs Industry: 3L3 underperformed the German Medical Equipment industry which returned -9.5% over the past year.
Return vs Market: 3L3 underperformed the German Market which returned 2.2% over the past year.
Price Volatility
| 3L3 volatility | |
|---|---|
| 3L3 Average Weekly Movement | 7.7% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 3L3 has not had significant price volatility in the past 3 months.
Volatility Over Time: 3L3's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 992 | Dan Reuvers | tactilemedical.com |
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders.
Tactile Systems Technology, Inc. Fundamentals Summary
| 3L3 fundamental statistics | |
|---|---|
| Market cap | €323.88m |
| Earnings (TTM) | €26.68m |
| Revenue (TTM) | €256.75m |
12.1x
P/E Ratio1.3x
P/S RatioIs 3L3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3L3 income statement (TTM) | |
|---|---|
| Revenue | US$274.42m |
| Cost of Revenue | US$79.29m |
| Gross Profit | US$195.13m |
| Other Expenses | US$166.62m |
| Earnings | US$28.52m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 06, 2024
| Earnings per share (EPS) | 1.20 |
| Gross Margin | 71.11% |
| Net Profit Margin | 10.39% |
| Debt/Equity Ratio | 15.0% |
How did 3L3 perform over the long term?
See historical performance and comparison